These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 10828888)
1. Breast cancer growth inhibition by delivery of the MDGI-derived peptide P108. Wang HL; Kurtz A Oncogene; 2000 May; 19(20):2455-60. PubMed ID: 10828888 [TBL] [Abstract][Full Text] [Related]
2. Local control of mammary gland differentiation: mammary-derived growth inhibitor and pleiotrophin. Kurtz A; Spitzer E; Zschiesche W; Wellstein A; Grosse R Biochem Soc Symp; 1998; 63():51-69. PubMed ID: 9513711 [TBL] [Abstract][Full Text] [Related]
3. Response of different mammary epithelial cell lines to a mammary derived growth inhibitor (MDGI). Lehmann W; Widmaier R; Langen P Biomed Biochim Acta; 1989; 48(1):143-51. PubMed ID: 2775246 [TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor. Huynh HT; Larsson C; Narod S; Pollak M Cancer Res; 1995 Jun; 55(11):2225-31. PubMed ID: 7757968 [TBL] [Abstract][Full Text] [Related]
5. Induction of mammary differentiation by mammary-derived growth inhibitor-related gene that interacts with an omega-3 fatty acid on growth inhibition of breast cancer cells. Wang M; Liu YE; Ni J; Aygun B; Goldberg ID; Shi YE Cancer Res; 2000 Nov; 60(22):6482-7. PubMed ID: 11103817 [TBL] [Abstract][Full Text] [Related]
6. Silencing of the mammary-derived growth inhibitor (MDGI) gene in breast neoplasms is associated with epigenetic changes. Huynh H; Alpert L; Pollak M Cancer Res; 1996 Nov; 56(21):4865-70. PubMed ID: 8895735 [TBL] [Abstract][Full Text] [Related]
7. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
8. Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23. Tseng YH; Vicent D; Zhu J; Niu Y; Adeyinka A; Moyers JS; Watson PH; Kahn CR Cancer Res; 2001 Mar; 61(5):2071-9. PubMed ID: 11280768 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth. Liu Y; Ludes-Meyers J; Zhang Y; Munoz-Medellin D; Kim HT; Lu C; Ge G; Schiff R; Hilsenbeck SG; Osborne CK; Brown PH Oncogene; 2002 Oct; 21(50):7680-9. PubMed ID: 12400010 [TBL] [Abstract][Full Text] [Related]
10. Differential regulation of cell proliferation and protease secretion by epidermal growth factor and amphiregulin in tumoral versus normal breast epithelial cells. Silvy M; Giusti C; Martin PM; Berthois Y Br J Cancer; 2001 Apr; 84(7):936-45. PubMed ID: 11286474 [TBL] [Abstract][Full Text] [Related]
11. The human mammary-derived growth inhibitor (MDGI) gene: genomic structure and mutation analysis in human breast tumors. Phelan CM; Larsson C; Baird S; Futreal PA; Ruttledge MH; Morgan K; Tonin P; Hung H; Korneluk RG; Pollak MN; Narod SA Genomics; 1996 May; 34(1):63-8. PubMed ID: 8661024 [TBL] [Abstract][Full Text] [Related]
12. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1. Hu M; Wang J; Chen P; Reilly RM Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139 [TBL] [Abstract][Full Text] [Related]
13. Anti-prostate cancer and anti-breast cancer activities of two peptides derived from alpha-fetoprotein. Caceres G; Dauphinee MJ; Eisele LE; MacColl R; Mizejewski GJ Anticancer Res; 2002; 22(5):2817-20. PubMed ID: 12530002 [TBL] [Abstract][Full Text] [Related]
14. Mammary-derived growth inhibitor alters traffic of EGFR and induces a novel form of cetuximab resistance. Nevo J; Mattila E; Pellinen T; Yamamoto DL; Sara H; Iljin K; Kallioniemi O; Bono P; Heikkilä P; Joensuu H; Wärri A; Ivaska J Clin Cancer Res; 2009 Nov; 15(21):6570-81. PubMed ID: 19825952 [TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer. Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460 [TBL] [Abstract][Full Text] [Related]
16. Antiprogestins inhibit growth and stimulate differentiation in the normal mammary gland. Li M; Spitzer E; Zschiesche W; Binas B; Parczyk K; Grosse R J Cell Physiol; 1995 Jul; 164(1):1-8. PubMed ID: 7790381 [TBL] [Abstract][Full Text] [Related]
17. Heparin/heparan sulfate interacting protein expression and functions in human breast cancer cells and normal breast epithelia. Jacobs AL; Julian J; Sahin AA; Carson DD Cancer Res; 1997 Nov; 57(22):5148-54. PubMed ID: 9371517 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2. Liu J; Yuan Y; Huan J; Shen Z Oncogene; 2001 Jan; 20(3):336-45. PubMed ID: 11313963 [TBL] [Abstract][Full Text] [Related]
19. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells. Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849 [TBL] [Abstract][Full Text] [Related]
20. Midregion parathyroid hormone-related protein inhibits growth and invasion in vitro and tumorigenesis in vivo of human breast cancer cells. Luparello C; Romanotto R; Tipa A; Sirchia R; Olmo N; López de Silanes I; Turnay J; Lizarbe MA; Stewart AF J Bone Miner Res; 2001 Dec; 16(12):2173-81. PubMed ID: 11760830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]